Skip to content

The comparative evaluation of ibuprofen & gabapantin on postendodontic pain.

The comparative evaluation of ibuprofen & gabapantin on postendodontic pain.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201205069564N1
Enrollment
40
Registered
2012-06-19
Start date
2011-12-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Accute irreversible pulpit. Pulpitis

Interventions

Intervention 1: Gabapantin as capsul 300mg, 600 mg 1hour pretreatment, 300mg post treatment any 6 hours for 1day. Intervention 2: Ibuprofen as capsul 400mg,800 mg 1 hour pretreatment, 400 mg post trea
Treatment - Drugs
Gabapantin as capsul 300mg, 600 mg 1hour pretreatment, 300mg post treatment any 6 hours for 1day.
Ibuprofen as capsul 400mg,800 mg 1 hour pretreatment, 400 mg post treatment every 6 hours for 1 day.

Sponsors

Babol University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 149 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age more than 15 years old; pian level moderate to sever(VAS more than 40mm) and clinical diagnosis reffering ireversible accute pulpitis on inferior first molar. Exclusion criteria: antibiotic therapy one week before the study; analgesia therapy 6 hours before intervention; history of mental desease, epilepsy; consumption of any epilepsy drug and history of systemic desease.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: 1 hour pre operation, hourly till 6 hours and 12, 24 and 48 hours after operation. Method of measurement: VAS.

Secondary

MeasureTime frame
Side effect. Timepoint: Up to 2 days post treatment. Method of measurement: Question form.;Evaluation of drug efficacy. Timepoint: Up to 2days post treatment. Method of measurement: Question form.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbas Mesgarani

Babol University of Medical Sciences

a_mesgarani@yahoo.com+98 11 1229 1408

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026